Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer
Status:
Terminated
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This study is conducting an evaluation of two chemotherapy drugs, Velcade and Irinotecan, in
women with advanced, recurrent, or metastatic cervical cancer, vaginal cancer, or vulvar
cancer. Patients with cervical cancer may have received a platinum-containing treatment as
systemic therapy without radiation, but is not required.